Loading viewer...
investor_presentation
Format: PDF investor_presentation
Solvay investor presentation dated February 2019.
Full Year 2018 Results FORENOTE
Following the announcement in September 2017 of plans to divest the Polyamide business, these have been reclassified as disconti nued
operations and as assets held for sale. For comparative purposes, the first quarter of the 2017 income statement has been res tated.
Besides IFRS accounts, Solvay also presents underlying Income Statement performance indicators to provide a more consistent and
comparable indication of the Group’s financial performance. The underlying performance indicators adjust IFRS figures for the non-cash
Purchase Price Allocation (PPA) accounting impacts related to acquisitions, for the coupons of perpetual hybrid bonds, classi fied as equity
under IFRS but treated as debt in the underlying statements, and for other elements that would distort the analysis of the Gr oup’s underlying
February 27, 2019 2018 Results 2 2018
February 27, 2019 2018 Results 3 February 27, 2019 2018 Results STRONG VOLUME GROWTH AND SUSTAINED MARGINS
3% higher volumes across segments
Net pricing maintained despite higher raw materials and
Higher fixed costs reflect investments to support growth
Lower financing payments on continued deleveraging
Capex discipline maintained
Working capital phasing
[1] Free cash flow after financing payments and minority interests € 725 m
to Solvay shareholders[1]
continuing operations
4 February 27, 2019 2018 Results ORGANIC EBITDA GROWTH DRIVEN BY HIGHER VOLUMES
Volume growth across main end- markets:
automotive, aerospace, healthcare
Impact from anticipated volume decrease
in smart devices, automotive diesel catalysts and insulation
Performance Chemicals
Strong performance in peroxides and favorable
market conditions in Brazil, supporting volumes and pricing.
Solid demand and improving soda ash prices
limited margin erosion Advanced Formulations
Strong volume growth in oil & gas in first
half followed by significant decline in fourth quarter
Preview truncated — download the full document for the complete content.
earnings
28 Pages
investor_presentation
29 Pages
Live Oak Bancshares
Varian Medical Systems Investor Presentation — April 2019
investor_presentationinvestor_presentation
33 Pages
Varian Medical Systems, Inc.
Marriott Vacations Worldwide Investor Presentation 2023
investor_presentationinvestor_presentation
35 Pages
Marriott Vacations Worldwide